Novo Nordisk has claimed a key win in its head-to-head race with Agios to bring an oral PKR activator to the market for sickle cell
Companies looking to push the limits of artificial intelligence in healthcare are heading to Utah, where the state is giving them flexibility to use the
The LITESPARK-012 trial saw no benefit when Welireg was added to treatment with Keytruda plus Lenvima for renal cell carcinoma.
Jazz’s biliary tract cancer drug Ziihera and Lilly’s Jaypirca for chronic lymphocytic leukaemia have been backed for NHS use in new NICE guidance.
The bleak European approval potential for Soleno Therapeutics’ genetic obesity drug essentially forced the US drugmaker to sell itself for less than it was once
UCB is teaming with the Myasthenia Gravis Foundation of America and Factor Meals to provide premade meals to 250 families affected by myasthenia gravis, a chronic disease that can cause muscle weakness, fatigue and swallowing problems that make mealtimes especially difficult.
Copyright 2025 dijee Intelligence Ltd. dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844